Detalles de la búsqueda
1.
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 23(7): 919-930, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35690073
2.
The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary Cholangitis.
Hepatology
; 74(6): 3269-3283, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34129689
3.
Effects of Primary Biliary Cholangitis on Quality of Life and Health Care Costs in the United Kingdom.
Clin Gastroenterol Hepatol
; 19(4): 768-776.e10, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32562892
4.
REFINE (REduced Frequency ImmuNE checkpoint inhibition in cancers): A multi-arm phase II basket trial testing reduced intensity immunotherapy across different cancers.
Contemp Clin Trials
; 124: 107030, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36519749
5.
Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis.
Gut Microbes
; 15(1): 2208501, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37191344
6.
Regulation of immune responses in primary biliary cholangitis: a transcriptomic analysis of peripheral immune cells.
Hepatol Commun
; 7(4)2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37026715
7.
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score.
Lancet Gastroenterol Hepatol
; 3(9): 626-634, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30017646
Resultados
1 -
7
de 7
1
Próxima >
>>